Table 2.
Association between SHR levels and the event risk.
| Groups | Unadjusted Cox analysis |
Adjusted Cox analysis |
||
|---|---|---|---|---|
| HR (95% CI) | p Value | HR (95% CI) | p Value | |
| MACE | ||||
| SHR, per 1SD increase | 2.73 (1.43–5.20) | 0.002 | 2.30 (1.21–4.38) | 0.011 |
| SHR tertile1 | 1 (Reference) | … | 1 (Reference) | … |
| SHR tertile2 | 2.10 (1.35–3.28) | 0.001 | 1.77 (1.14–2.73) | 0.010 |
| SHR tertile3 | 3.06 (2.01–4.65) | <0.001 | 2.64 (1.75–3.98) | <0.001 |
| Death, nonfatal MI, stroke or revascularization | ||||
| SHR, per 1SD increase | 2.80 (1.28–6.16) | 0.010 | 2.33 (1.07–5.08) | 0.033 |
| SHR tertile1 | 1 (reference) | … | 1 (reference) | … |
| SHR tertile2 | 1.69 (1.01–2.89) | 0.042 | 1.50 (0.88–2.55) | 0.130 |
| SHR tertile3 | 2.04 (1.23–3.37) | 0.005 | 1.88 (1.14–3.08) | 0.012 |
Association of SHR as a continuous variable (for per 1SD increase) and a categorical variable (tertile1 as reference) with the event risk. HR was adjusted for age, sex, MI type (NSTEMI or STEMI), hypertension, diabetes, dyslipidemia, LVEF and peak TnI in the multivariate model. HR: hazard ratio; CI: confidence interval; SD: standard deviation; SHR: stress hyperglycemia ratio; MACE: major adverse cardiovascular events; MI: myocardial infarction.